NO20044449L - Salter av tolterodin - Google Patents
Salter av tolterodinInfo
- Publication number
- NO20044449L NO20044449L NO20044449A NO20044449A NO20044449L NO 20044449 L NO20044449 L NO 20044449L NO 20044449 A NO20044449 A NO 20044449A NO 20044449 A NO20044449 A NO 20044449A NO 20044449 L NO20044449 L NO 20044449L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- carbon atoms
- tolterodine
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/127,875 US7005449B2 (en) | 2002-04-23 | 2002-04-23 | Tolterodine salts |
| PCT/SE2003/000634 WO2003090734A1 (fr) | 2002-04-23 | 2003-04-22 | Sels de tolterodine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044449L true NO20044449L (no) | 2004-10-26 |
Family
ID=29215346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044449A NO20044449L (no) | 2002-04-23 | 2004-10-19 | Salter av tolterodin |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7005449B2 (fr) |
| EP (1) | EP1496882B1 (fr) |
| JP (1) | JP2005535578A (fr) |
| KR (1) | KR20040104585A (fr) |
| CN (1) | CN1646110A (fr) |
| AP (1) | AP2004003160A0 (fr) |
| AT (1) | ATE334665T1 (fr) |
| AU (1) | AU2003237724A1 (fr) |
| BR (1) | BR0309439A (fr) |
| CA (1) | CA2483092A1 (fr) |
| DE (1) | DE60307258T2 (fr) |
| EA (1) | EA200401108A1 (fr) |
| EC (1) | ECSP045373A (fr) |
| ES (1) | ES2266828T3 (fr) |
| HR (1) | HRP20040990A2 (fr) |
| IL (1) | IL164109A0 (fr) |
| IS (1) | IS7462A (fr) |
| MA (1) | MA27197A1 (fr) |
| MX (1) | MXPA04010472A (fr) |
| NO (1) | NO20044449L (fr) |
| OA (1) | OA12810A (fr) |
| PL (1) | PL371743A1 (fr) |
| TN (1) | TNSN04212A1 (fr) |
| TW (1) | TW200306802A (fr) |
| WO (1) | WO2003090734A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7101888B2 (en) * | 2002-08-28 | 2006-09-05 | Pharmacia & Upjohn Company | Oral liquid tolterodine composition |
| US7393874B2 (en) * | 2003-04-08 | 2008-07-01 | Hetero Drugs Limited | Polymorphs of tolterodine tartrate |
| CA2522666A1 (fr) * | 2003-04-18 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Polytherapies |
| EP1701932B1 (fr) * | 2003-12-24 | 2012-07-18 | Cipla Ltd. | Tolterodine, compositions et leurs utilisations, et preparations desdites compositions |
| EP1629834A1 (fr) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Composition pharmaceutique de tolterodine avec liberation soutenue |
| ITMI20060110A1 (it) * | 2006-01-24 | 2007-07-25 | Dipharma Spa | Procedimento per la purificazione di tolterodina |
| US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| EP2175843B1 (fr) | 2007-08-08 | 2014-10-08 | Inventia Healthcare Private Limited | Compositions à libération prolongée comprenant de la toltérodine |
| KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
| US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
| ITMI20082055A1 (it) * | 2008-11-19 | 2009-02-18 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-tolterodina base libera |
| PL2416761T3 (pl) * | 2009-05-11 | 2015-07-31 | Ratiopharm Gmbh | Desfezoterodyna w postaci soli kwasu winowego |
| IT1396373B1 (it) * | 2009-10-29 | 2012-11-19 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina. |
| IT1403094B1 (it) | 2010-12-09 | 2013-10-04 | Dipharma Francis Srl | Procedimento per la preparazione di fesoterodina o un suo sale |
| GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
| AU2019310590A1 (en) | 2018-07-26 | 2021-01-14 | Sumitomo Pharma Oncology, Inc. | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same |
| CN111728957B (zh) * | 2020-07-06 | 2022-04-19 | 济南大学 | 一种托特罗定长效缓释微球及其制备方法 |
| CN111925294A (zh) * | 2020-07-06 | 2020-11-13 | 济南大学 | 一种托特罗定帕莫酸盐及其制备方法 |
| CN115814090B (zh) * | 2022-11-22 | 2024-05-24 | 广州医科大学附属第一医院 | 烟草引发炎症的药物靶点 |
| US12150922B1 (en) * | 2023-12-08 | 2024-11-26 | King Faisal University | Methods of inhibiting cyclooxygenase (COX) using tolterodine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5382600A (en) | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| SE9203318D0 (sv) | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| KR20000057548A (ko) | 1996-12-13 | 2000-09-25 | 알프레드 엘. 미첼슨 | 광학적 전송물질 및 결합재 |
| PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
-
2002
- 2002-04-23 US US10/127,875 patent/US7005449B2/en not_active Expired - Fee Related
-
2003
- 2003-04-22 MX MXPA04010472A patent/MXPA04010472A/es not_active Application Discontinuation
- 2003-04-22 AU AU2003237724A patent/AU2003237724A1/en not_active Abandoned
- 2003-04-22 AT AT03736380T patent/ATE334665T1/de not_active IP Right Cessation
- 2003-04-22 DE DE60307258T patent/DE60307258T2/de not_active Expired - Fee Related
- 2003-04-22 BR BR0309439-1A patent/BR0309439A/pt not_active IP Right Cessation
- 2003-04-22 KR KR10-2004-7016923A patent/KR20040104585A/ko not_active Ceased
- 2003-04-22 EA EA200401108A patent/EA200401108A1/ru unknown
- 2003-04-22 JP JP2003587370A patent/JP2005535578A/ja active Pending
- 2003-04-22 EP EP03736380A patent/EP1496882B1/fr not_active Expired - Lifetime
- 2003-04-22 PL PL03371743A patent/PL371743A1/xx unknown
- 2003-04-22 WO PCT/SE2003/000634 patent/WO2003090734A1/fr not_active Ceased
- 2003-04-22 IL IL16410903A patent/IL164109A0/xx unknown
- 2003-04-22 CA CA002483092A patent/CA2483092A1/fr not_active Abandoned
- 2003-04-22 AP APAP/P/2004/003160A patent/AP2004003160A0/en unknown
- 2003-04-22 ES ES03736380T patent/ES2266828T3/es not_active Expired - Lifetime
- 2003-04-22 HR HRP20040990 patent/HRP20040990A2/hr not_active Application Discontinuation
- 2003-04-22 TW TW092109359A patent/TW200306802A/zh unknown
- 2003-04-22 OA OA1200400285A patent/OA12810A/en unknown
- 2003-04-22 CN CNA038090643A patent/CN1646110A/zh active Pending
-
2004
- 2004-09-20 IS IS7462A patent/IS7462A/is unknown
- 2004-10-14 MA MA27908A patent/MA27197A1/fr unknown
- 2004-10-19 NO NO20044449A patent/NO20044449L/no not_active Application Discontinuation
- 2004-10-21 EC EC2004005373A patent/ECSP045373A/es unknown
- 2004-10-22 TN TNP2004000212A patent/TNSN04212A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2004003160A0 (en) | 2004-12-31 |
| ECSP045373A (es) | 2004-11-26 |
| TNSN04212A1 (fr) | 2007-03-12 |
| MXPA04010472A (es) | 2005-07-14 |
| CA2483092A1 (fr) | 2003-11-06 |
| US7005449B2 (en) | 2006-02-28 |
| US20030199582A1 (en) | 2003-10-23 |
| KR20040104585A (ko) | 2004-12-10 |
| EP1496882B1 (fr) | 2006-08-02 |
| HRP20040990A2 (en) | 2004-12-31 |
| JP2005535578A (ja) | 2005-11-24 |
| EA200401108A1 (ru) | 2005-06-30 |
| ES2266828T3 (es) | 2007-03-01 |
| EP1496882A1 (fr) | 2005-01-19 |
| IL164109A0 (en) | 2005-12-18 |
| WO2003090734A1 (fr) | 2003-11-06 |
| CN1646110A (zh) | 2005-07-27 |
| OA12810A (en) | 2006-07-11 |
| BR0309439A (pt) | 2005-02-15 |
| IS7462A (is) | 2004-09-20 |
| TW200306802A (en) | 2003-12-01 |
| PL371743A1 (en) | 2005-06-27 |
| ATE334665T1 (de) | 2006-08-15 |
| AU2003237724A1 (en) | 2003-11-10 |
| DE60307258D1 (de) | 2006-09-14 |
| DE60307258T2 (de) | 2007-10-25 |
| MA27197A1 (fr) | 2005-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20044449L (no) | Salter av tolterodin | |
| EP0867179B1 (fr) | Composition d'esters du L-dopa | |
| WO2001019776A3 (fr) | Nouveaux derives d'acide dicarboxylique presentant des proprietes pharmaceutiques | |
| PL354004A1 (en) | Novel dicarboxylic acid derivatives with pharmaceutical properties | |
| NO20051265L (no) | Anvendelse av og noen nye imidazopyridiner | |
| WO2001019780A3 (fr) | Nouveaux derives d'acide aminodicarboxylique presentant des proprietes pharmaceutiques | |
| DK0661269T3 (da) | Substituerede heterocykliske carboxylsyreamider, deres fremstilling og anvendelse som lægemidler. | |
| EP1807412A1 (fr) | Urees diaryle cycliques en tant qu'inhibiteurs de la tyrosine kinase | |
| CA2445145A1 (fr) | Derives d'oxazole substitues par de l'acide carboxylique utiles en tant qu'activateurs ppar-alpha et gamma dans le traitement du diabete | |
| WO2002080899A1 (fr) | Agent de traitement de maladie digestive | |
| JP2005519073A (ja) | 睡眠標的モジュレーターを使用する睡眠障害の治療 | |
| HUT62264A (en) | Process for producing amidino compounds and pharmaceutical compositions comprising same as active ingredient | |
| ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
| EP1172107A4 (fr) | Medicaments contenant des derives du sulfopyranosylacylglycerol | |
| US5506264A (en) | Zinc tranexamate compounds | |
| HU9800970D0 (en) | Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica | |
| WO2007105021A3 (fr) | Sels de duloxetine | |
| US6469064B2 (en) | Materials and methods for the treatment of depression | |
| CN113512025B (zh) | 一种吲唑酯类化合物及其制药用途 | |
| US20090298893A1 (en) | Addition Salts of Tolperisone, Processes for Their Preparation and Use Thereof | |
| NO20045223L (no) | Orto-substituerte benzosyrederivater for behandling av insulinresistens | |
| US3903165A (en) | Ethynylaryl amines and processes for their preparation | |
| SI1501823T1 (sl) | Novi piperidinil-alkilamino-piridazinonski derivati, postopek za njihovo pripravo in farmacevtski sestavki, ki vsebujejo te spojine | |
| JP2006169176A (ja) | 抗コロナウイルス活性を有するインドリル−ペンテン−ジオン誘導体 | |
| RU95107150A (ru) | Производные пиридобензоксадиазинкарбоновой кислоты, смесь их изомеров или отдельные изомеры, их фармацевтически используемые гидраты и соли, промежуточные продукты для их получения, а также фармацевтическая композиция с антибактериальной активностью на их основе |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |